Welcome to the World’s Largest Industry-Dedicated Gathering for mRNA Professionals
The world's first non-COVID mRNA approval from Moderna has spurred a new wave of candidates moving into early-to-late-stage clinical development for rare, infectious and oncological indications. With tremendous strides in the industry, the 4th mRNA-Based Therapeutics Summit cemented its position as the world's largest, end-to-end mRNA conference, bringing attendees exclusive scientific and strategic insights from the biggest players across indications and modalities.
In July, 375+ mRNA experts and enthusiasts hears previously-unseen data insights from 65+ world-class speakers from the likes of CureVac, Moderna, BioNTech and Sanofi, and gained exclusive regulatory insights from the FDA, MHRA and EMA.
Insert quote here for testimonials with company logo. Set the width of logo to 140 px at all device displays.
Name, Job Title, Company
A great way to get updated on the latest innovations in all aspects of mRNA therapeutics development from discovery/delivery to CMC and connect with leading experts in the field.
Beata Chertok, Team Lead, Delivery of Intracellular Biologics, AstraZeneca
This was an opportunity to better understand the industry’s needs, and explain the FDA’s expectations.
Peter Marks, Director CBER
Explore the Full Event Guide
- 65+ expert speakers
- 3 days of data-driven content
- Exclusive regulatory insights
- Interactive roundtables
- CXOs’ panel discussion
Official Partners
Lead Partner
Expertise Partners
Exhibition Partners
Innovation Partner
Attending Companies
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive regulatory insights during our packed agenda, interactive roundtables, and new CXOs’ panel discussion.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.
